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Abstract
Autofluorescence of the bone extracellular matrix (ECM) has not been widely explored although the ECMplays a very important
role in bone development. In our research we focused on examining the bone matrix of very young animals due to the intense
growth process during the first month of life. Structure images and fluorescence spectra of the bone surface were carried out using
confocal fluorescence microscope Eclipse Ti-S inverted CLSM (NIKON, Japan) for compact tibia of healthy 7-, 14- and 28-day-
old rat newborns after prenatal zidovudine administration in comparison with control. Spectral features of ECM autofluorescence
were analyzed statistically by taking into consideration p < 0.05. The CLSM technique allows for simultaneous examination of
the structure and autofluorescence from selected areas of the bone surface. Excessive autofluorescence of ECM after prenatal
zidovudine administration influences bone growth incommensurably to the newborns’ age. Therefore the possibility of an
additional non-enzymatic mechanism of collagen cross-linking in the first two weeks of life of newborn rats prenatally treated
with zidovudine has been considered. Our results suggest that ECM autofluorescence can be an indicator of bone development in
the normal and pathological state.
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Introduction
Bone is a complex tissue whose proper functioning is
based on cooperation between living cells (osteoblasts, os-
teoclasts, and osteocytes) and extracellular matrix (ECM)
composed of organic matter dominated by collagen pro-
teins and the inorganic component consisting mainly of
hydroxyapatite. Nowadays anatomy and physiology of
bone system and its cells are well described. Recently nor-
mal osteogenesis and bone development during whole hu-
man or mammalian life as well as mechanisms of disorders
detected in bone physiology and bone growth have been
researched by many authors, i.e. [1–6].
Our earlier work on bone focused on studies of the effect of
antiretroviral drugs, such as zidovudine or indinavir, that are
used among others to treat the HIV infections, on bone tissue
development in an animal model [7–9]. It was shown using
the XRF technique that maternal administration of indinavir
disturbs concentration of elements of inorganic matter, espe-
cially in trace elements such as zinc and strontium whose
content changes regulate the Ca level. On the other hand,
prenatal zidovudine treatment influenced organic matter to a
greater extent, which we revealed by using laser fiber spec-
troscopy. However, it is interesting to deepen investigation of
ECM using confocal laser scanning microscope with the op-
tion of obtaining spectra from a specific microscopic area.
Advanced microscopic techniques including multi-photon
microscopy are often applied in characterization of biological
tissues including bone in biomedical research of oncological
as well as non-oncological cases associated with environmen-
tal stress, genetic manipulation and drug treatment [10–13].
CLSM has been an effective tool for investigating bone calci-
fication [14] as well as the cells embedded within the miner-
alized bone matrix. Bone-resorbing osteoclasts can be ana-
lyzed by confocal microscopy [15]. Combined CLSM and
Differential Interference Contrast (DIC) microscopy methods
were used for histotomography and 3D imaging of the struc-
ture and processes of osteocytes [16]. Non-destructive
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complementary imaging of cancellous bone contributed to the
understanding of its bimodal structure, which is important for
the development of tissue engineering. Analyzes of confocal
images of microcracks in relation to biomechanical properties
of ageing human cortical bone were also reported [17].
This paper presents the usefulness of confocal fluorescence
microscopy for testing the physiological development of the
bone matrix in the first month of life and the potentially neg-
ative effect of prenatal treatment with zidovudine. For this
purpose, confocal images have been analyzed to reveal chang-
es caused by the anti-HIV treatment in patterns of extracellular
matrix of developing bones. Moreover, we found it worth-
while to check if autofluorescence of ECM could be a marker
of bone development in the normal as well as pathological
state.
Material and Methods
The bones of newborn rats in three age groups (7-, 14- and 28-
day-old) received from Department of Pharmacology at the
Medical University of Silesia were used for this study. The
section of the rats was performed with the approval of The
Local Ethics Committee for Animal Experiments in Katowice
(no. 9/2008) according to the Helsinki Declaration in the
framework of the grant No.2POD08530 of the Polish
Ministry of Education and Science. The preparation process
of bone samples was described previously [7]. Tibias from rat
offspring whose mothers were administered with 0.9% NaCl
were compared to newborns’ bones whose mothers received
antiretroviral agent zidovudine at a 200 mg/kg [9]. Such a dose
was chosen on the basis of earlier reports [e.g. 18] as well as
our own experience, which indicated increasing mortality of
rat fetuses at higher doses. Zidovudine ZDV (aka.
azidothymidine) was one of the first medications used in anti-
retroviral therapy (ARV) as a representative of NRTIs
blocking the process of replication in infected cells [19, 20].
Unfortunately, genotoxic effects of such therapies were ob-
served, including negative influence on bone tissue [21, 22].
Hence study of bones from very young rats (less than one
month) is important due to the intense growth process in this
stage of development.
Measurements were performed for equinumerous groups
of bones (6 tibias each) from younger newborns 7- and 14-
day-old after maternal treatment with zidovudine and control,
7Z, 14Z, 7C and 14C, respectively. For 28-day-old rats only 4
tibias were measured in both control 28C and zidovudine 28Z
groups. The control groups are presumed to be healthy groups
of rats’ tibias, where bone development is physiologically
normal.
All samples were studied using Eclipse Ti-S inverted
CLSM (NIKON, Japan). The images of bone surface were
registered using 20x objective lens (NA 0.45) giving final
zoom equal to 200x. To provide the best visibility the confocal
plane was set on the flattest surface of the sample. As an
excitation source for autofluorescence study, 404 nm laser
diode (Melles Griot, <500 mW) was used because such exci-
tation wavelength was found to produce the highest contrast in
detecting early lesions [10, 23]. Emission signal was detected
by the photomultiplier (PMT) with spectral resolution set at
5 nm in the range of 400–700 nm. Autofluorescence spectra
were collected from images of compact bone surface near
diaphysis focusing on intercellular substance of bone where
circular ROIs (diameter 20 ± 5 μm) were assigned within con-
focal plane to reduce the noise of emission signal (5–6 ROIs in
each sample). Background spectrum including laser beam
spectrum and PMT noise was also recorded.
All spectral measurements were formulated using Origin
(OriginLab, USA) software. Originally recorded fluorescence
spectra from tibia of newborns rats were normalized to the
maximum of excitation peak in measured tissue and then the
background signal was subtracted. Moreover, spectra were
normalized to average intensity calculated in the 650–
700 nm range for all spectra. Such a procedure was used
earlier by Mayinger et al. [24] as optimal for investigation of
biological samples whose emission signal depends on the il-
lumination and the position of the probe. This method takes
into account data averaging, normalization and subtraction.
This allows us to compare the fluorescence plots and to reveal
substantial differences between registered spectra.
Statistical analysis was performed using STATISTICA12
software (StatSoft, USA). Obtained results of measurements
were processed to eliminate outliers (Grubbs test). Results
were distributed normally according to the normality tests
(Kolmogorov-Smirnov). In the statistical calculations the
standard level of confidence was assumed to be p = 0.05 for
ANOVA tests to estimate the presence of statistical differences
amongst analyzed groups.
Results
Confocal Fluorescence Microscopy Imaging
Representative images of age-related development of compact
bone surface architecture within diaphysis of tibia are present-
ed in Fig. 1. In fact, they reveal organic extracellular matrix
(ECM, osteoid), composed mostly of type I collagen that
gradually mineralizes to form mature bone. Collagen fibrins
are the most fluorescent matter observed in the confocal plane
contrasting with black areas which probably originate from
the blood vessel canals (Volkmann’s canals supplying nutri-
tional ingredients necessary for bone development) as well
numerous lacunae visible in particular in the tibia of the youn-
gest newborns.
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Images registered by our microscope show eye-catching
differences in size, architecture and distribution of histological
elements between the studied bone groups. To assure descrip-
tion clarity control and zidovudine groups are considered
separately.
Imaging revealed fragile structure of ECM in the 7C group
what is presented in Fig. 1a. Bone surface shows an irregular
and spongy architecture with supramolecular structure of col-
lagen fibrils suggesting a presence of trabecular meshwork at
the beginning of bone development. Fig. 1b displays bone
matrix patterning in 14-day-old rat bone (14C), altered a little
due to increasing of collagen cross-linking and progressive
bone mineralization. Further mineralization of proteinaceous
matrix leads to the formation of dense cortical bone. Surface
of the tibia from the 28C group (Fig. 1c) demonstrates an
almost mature compact bone as a result of matrix conforma-
tion from woven to lamellar bone and the process of
mineralization.
Process of bone development during the first month of life
of rat newborns prenatally treated with zidovudine is presented
in Fig. 1d – f. Tibia of 7-day-old newborns (7Z) also show a
spongy structure but self-assembly of collagen molecules into
collagen fibers seems to be more advanced than in the control
group (see Fig. 1d vs. a). The distinct differences in the pattern
of collagen forming osteoid are observed in bones of 14-day-
old newborns. Circularity of Volkmann’s canals is still notice-
able but the collagen fibrils are clustered in parallel or concen-
tric arrays characteristic for lamellar bone [1, 2]. Nevertheless,
it should be noted that tibias of zidovudine groups are mark-
edly bigger than the control ones in each age group.
Autofluorescence Spectra
Autofluorescence spectra of the bone organic ECM measured
in our experiment are presented in Fig. 2. As hydroxyapatite-
like compounds are not fluorescent so the presence of it could
be omitted. The characteristic broad band of emission with
peak at about 480 nm is observed; apparent side band on part
of longer wavelengths is found in all studied samples. Such a
signal is similar to fluorescence spectra of biological tissues
obtained by fiber laser spectroscopy described by various re-
searchers earlier [9, 23, 24]. Autofluorescence in our experi-
ment is attributed to closely spaced overlapping emissions
generated by a number fluorescent compounds such as: colla-
gen, NAD(P)H, flavins, fatty acids, vitamins and lipofuscins -
see literature [25].
Fig. 1 Representative age relative images of the tibia diaphysis surface of control newborn rats: a - 7C, b -14C, c - 28C, and prenatal zidovudine treated
newborns: d - 7Z, e - 14Z, f - 28Z. In picture B) the Volkamnn’s channels VC and lacunae L are marked. Zoom 200x, scale bar: 100 μm
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Emission spectra (shown in Fig. 2) disclose similar shape in
all groups but the intensity of fluorescence depends on drug and
age of newborns. Fluorescence normally increases with the age
of newborn rats, but prenatal zidovudine drug delivery enhances
the signal. The mentioned increase in the zidovudine group
seems to be actually dependent on both ageing and drug admin-
istration processes but in different way. Therefore for better
insight into the problem we analyzed: fluorescence intensity,
peak position and difference in maximum between the studied
groups. These basic spectral parameters allowed for a fuller
description of phenomena during our study - they are listed in
Table 1. For 7- and 14-day-old groups maximum peaks are
located at 482.5 nm, while for the 28C and 28Z groups a blue-
shift of maximum appears: at 15 nm and 10 nm, respectively.
Analysis of the variation of emission intensity indicates
statistically significant differences (p < 0.001) regards age for
the control bones as well as for the zidovudine group.
However, no significant differences are found for groups be-
tween 14C and 7Z as well as between 14Z and 28C. This
means that the fluorescence of bones of older rats from the
control group is close to the emission of bones of younger rats
from the zidovudine group. Age-dependent development rate
of osteoid is estimated as a mathematical intensity subtraction
Δintensity (Table 1). During the first 2 weeks of rats’ life pre-
natal drug administration causes faster increase of fluores-
cence peak intensity compared with the increase observed in
the control group. However, a different effect inΔintensity was
found for the next life period, between the fourth and second
week of life (28d – 14d). The difference in fluorescence peak
intensity is smaller in the zidovudine group than in the control
group unlike the first two weeks of rats’ lives. Hence at the
end of the experiment taking into account the difference be-
tween the last and first week of rats’ life (28d – 7d) – a sup-
pression of fluorescence intensity increase between
zidovudine and control groups was observed.
Mechanisms of bone development can be better understood
by using the normalized differential spectra of osteoid auto-
fluorescence. Emission differences between the zidovudine
group and the control group for different age of newborns is
displayed in Fig. 3.
Fig. 2 Average autofluorescence spectra of bone extracellular matrix frommaternal zidovudine treatment group (a) and control (b) as a function of age (d
– day-old) under 404 nm laser excitation
Table 1 Mean intensity of
osteoid fluorescence in maximum
emission peak as a function of
rat’s newborns age for control
group compared with zidovudine
group and intensity difference for
successive age groups (C –
control group, Z – zidovudine
group, d – day-old)
Group Parameters Intensity difference between age
groupsΔintensity
Maximum emission λmax [nm] Maximum intensity Imax [a.u.] 14d - 7d 28d - 14d 28d -7d
7C 482.5 ± 2.5 6.87 ± 0.91
14C 482.5 ± 2.5 9.43 ± 1.17 2.56
28C 467.5 ± 2.5 12.56 ± 0.63 3.13 5.69
7Z 482.5 ± 2.5 8.63 ± 0.51
14Z 482.5 ± 2.5 12.20 ± 0.96 3.57
28Z 472.5 ± 2.5 14.28 ± 0.46 2.08 5.65
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The largest excessive signal is found in bones from 14-day-
old rats. The line shape reveals many component perturbations
occurring through the range of the studied wave lengths.
Broad signal (FWHM= 154 ± 14 nm) with maximum intensi-
ty (a.u.: 0,32 ± 0,05) located at about 482,5 nm singles out this
group from among others. For 7-day-old rats a strong blue-
shift maximum about 25 nm in respect to the 14-day-old
group is noticeable. Differential plot of autofluorescence of
tibia taken from 28-day-old rats shows the smallest excessive
signal (FWHM= 96 ± 8 nm) among the studied age groups
but is shifted towards red with respect to the group of
14 day old rats - located near 502,5 nm. It follows from our
analysis that contributions of different endogenic fluorophores
change at a varying degree with rat age.
Discussion
In our study we focused on monitoring the development of
bone matrix in newborn rats using confocal fluorescence
microspectroscopy which allows to investigate selected tissue
on microscopy level. The differentiated patterning of bone
matrix from an initial trabecular meshwork towards dense
cortical bone dependent on status bone tissue could be ob-
served (Fig. 1). As expected, the obtained confocal images
confirm that organic extracellular matrix is dominated by col-
lagen fibrils which constitute ca. 85% of bone ECM [1].
Important aspects of alternations in bone extracellular matrix
during the first month of rat newborns life are reflected in the
autofluorescence measurements. It should be noted that pro-
gressive mineralization does not reduce collagen emission, as
previously mentioned [26]. It is noteworthy that age and drug
related changes in autofluorescence spectra of newborn rats’
bone matrix on microscope level are in a good quality agree-
ment with results obtained from 1,8 mm diameter circular
areas of compact bone by fiber laser spectroscopy [7, 9] for
younger newborns.
An age-increasing autofluorescence of bone matrix seems
to be primarily associated with the increasing number of fluo-
rescent molecules, mainly of collagen ones emitting in the
range 400–510 nm [25]. However, our preliminary study of
autofluorescence of the surface of the compact bone by steady
fluorescence spectroscopy [9] suggested essential contribu-
tions generated not only by collagen but also by nicotinamide
adenine dinucleotide (NAD(P)H) in the visible range of wave-
lengths. Basing on autofluorescence under excitation of
404 nm obtained in this framework, it is difficult to precisely
determine collagen and NAD(P)H contributions due to their
overlapping emissions. In addition, the fluorescence contribu-
tions may not be additive due to complicated interactions of
the fluorophores with the molecular environment. Detail anal-
yses of collagen and (NAD(P)H), as two of the major tissue
fluorescent biomarkers of pre- and cancerous changes were
performed using Monte Carlo technique [27], chemometric
tools [28] and MCR-ALS method [29].
Bone matrix is mostly composed of collagenous proteins
but non-collagenous proteins (10 to 15% of total bone protein)
including proteoglycans, glycosylated proteins, gamma–
carboxylated (gla) proteins and 2HS-glycoprotein may affect
bone cell activity and regulate bone mineral deposition [1].
The most prevalent non-collagenous protein - osteonectin,
(approximately 2% of total protein in developing bone) is
thought to affect osteoblast growth and matrix maturation reg-
ulating fibril diameter. On the other hand, calcium- and
phosphate-binding proteins such as osteocalcin, osteopontin,
bone sialoprotein and alkaline phosphatase participate in ma-
trix mineralization by regulating the amount and size of hy-
droxyapatite crystals formed. Such an imposition of men-
tioned tissue processes must be taken into account during
studies when prenatal treatment with antiretroviral drugs is
used. It is clear that therapy in pregnancy affects the develop-
ment of young bone, especially altering the activity of osteoid
proteins and coenzymes. It was reported that the activity of
zidovudine as a nucleoside analogue which competes with
natural metabolites for an active place in enzymes may disturb
their functions [19, 30].
The effect of maternal therapy with zidovudine on bone
tissue formation revealed in our studies the increase of ECM
emission which is in opposition to fluorescence decrease in
malignant bone cells [23]. Unfortunately, in our work similar
trends in ECM autofluorescence changes with respect to age
and prenatal pathology (Fig. 2, Table 1) make this analysis
difficult. Only normalized differential spectra enabled specifi-
cation of bone tissue in relation to newborns prenatally treated
with zidovudine. Spectral profiles of differential plots of bone
ECM (Fig. 3) point to the age dependent excess of emission
with the shifting of the maximum towards the shorter wave-
lengths for the younger rats in comparison with the oldest
Fig. 3 Differential plots of osteoid emission normalized to control,
obtained for tibia taken from newborns after maternal treatment with
zidovudine and control in all studied age groups (Z – zidovudine group,
C- control)
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ones. Such behavior of the differential spectrum can be asso-
ciated with the different degree of maturation of collagen fi-
bers stimulated by altering protein growth factors as well as by
possible changes in fluorescence signals of metabolic en-
zymes ratios, like NAD(P)Hbound/free, and NAD(P)Htotal/oxi-
dized flavins on which the spectral shape can depend, as
discussed in [25].
It was presented by Bailey et al. [31] that collagen cross-
linking involves two different mechanisms, one enzymati-
cally controlled cross-linking during development and
maturation and the other an adventitious non-enzyme
mechanism following maturation of the tissue. Advanced
glycation end products (AGEs) are thought to be the major
cause of the dysfunction of collagenous tissues in ageing,
osteoporosis, diabetes [32] as well in cardiovascular dis-
eases [33]. It is not excluded that an additional non-
enzymatic cross-linking may have pathophysiological im-
plications in bone ECM of rat newborns with maternal
administrated zidovudine, especially during the first two
weeks of rat’ life. Too rapid, non–adequate to age increase
of collagen cross-linkage could be interpreted as a prema-
ture process of ageing of collagenous tissue during bone
development. Taking into consideration the maximum
fluorescence of AGEs about 440–450 nm occurring in bi-
ological substances, it seems likely that the abnormal in-
crease in intensity blue-shifted fluorescence part of differ-
ential spectra is due to the additional emission of AGEs
deposits in bone ECM of younger newborn rats, especially
7-day old ones. Differential spectrum of 14-day old rats is
additionally influenced by fluorescence contribution cov-
ering the yellow-reddish region in which lipofuscins or
lipofuscin-like lipopigments may emit (480–700 nm)
[25]. The presence of these fluorophores might be a marker
of the side effect of maternal treatment with drug on devel-
opment of the bone matrix. Earlier physiological intracel-
lular accumulation of lipofuscins in the central nervous
system with ageing as well as in response to pathological
conditions or to toxic compounds were reported [34].
Autofluorescence of lipofuscin in retinal pigment epitheli-
um due to Stargardt’s disease and age-related macular de-
generation [35, 36] was also discussed. In addition, even a
small amount of lipids in the mineralized bone tissue [37]
taking part in bone physiology in relation to their metabo-
lism may influence the differential spectra (Fig. 3) at about
470–480 nm.
A reduction of side effects of prenatal drug administration
was observed in the tibia of the oldest rats tested. It is note-
worthy that excessive contributions at the beginning and at the
end of the differentiated spectra disappear for tibia of the
28 day-old rats which might indicate a return to basic enzy-
matic cross-linking.
Conclusions
Our investigations show applicability of confocal laser scan-
ningmicroscopy for comprehensive characterization of organ-
ic extracellular matrix and its mineralization in the first month
of life of rat newborns. Changes in the pattern of collagen
forming the osteoid and differences in the emission of ECM
fluorophores allow to monitor bone development in the nor-
mal and disturbed state due to prenatally administration of
anti-HIV drug zidovudine. The possibility of an additional
non-enzymatic mechanism of collagen cross-linking in the
first two weeks of life of newborn rats is considered. ECM
autofluorescence can be an indicator of bone development and
hence may be useful in clinical trials.
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